GlobeNewswire Inc.··NaPharming Group Boosts Investor Outreach Amid Leniolisib CHMP Approval Win
Pharming Group schedules April 2026 investor conferences following positive CHMP opinion for Joenja® leniolisib in APDS treatment.
PHARinvestor conferencebiopharmaceutical